The investment seeks long-term capital appreciation... Show more
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Category SmallBlend
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| GCIAX | 18.81 | 0.10 | +0.53% |
| Goldman Sachs Intl Eq Insghts A | |||
| ANVRX | 10.97 | 0.04 | +0.37% |
| American Century Non-US Intrs Val R | |||
| IVGAX | 20.52 | 0.03 | +0.15% |
| VY® Invesco Growth and Income A | |||
| PHPSX | 29.22 | 0.04 | +0.14% |
| ProFunds Pharmaceuticals UltraSector Svc | |||
| GLCTX | 30.75 | -0.64 | -2.04% |
| Goldman Sachs Large Cap Gr Insghts Inv | |||
A.I.dvisor indicates that over the last year, CRMAX has been closely correlated with VEXMX. These tickers have moved in lockstep 95% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRMAX jumps, then VEXMX could also see price increases.
| Ticker / NAME | Correlation To CRMAX | 1D Price Change % | ||
|---|---|---|---|---|
| CRMAX | 100% | +0.09% | ||
| VEXMX - CRMAX | 95% Closely correlated | -0.20% | ||
| VIEIX - CRMAX | 95% Closely correlated | -0.20% | ||
| NAESX - CRMAX | 94% Closely correlated | +0.12% | ||
| FSMDX - CRMAX | 93% Closely correlated | N/A | ||
| FSMAX - CRMAX | 92% Closely correlated | N/A | ||
More | ||||